½ÃÀ庸°í¼­
»óǰÄÚµå
1534360

¼¼°èÀÇ Àΰø°Ç ¹× ÀÎ´ë ½ÃÀå - ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®, ±âȸ, ¿¹Ãø º¸°í¼­(2019-2030³â)

Artificial Tendons and Ligaments Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product Type; By Application; By End User; By Material; By Country

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Blueweave Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 400 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Àΰø°Ç ¹× ÀÎ´ë ¼¼°è ½ÃÀå ±Ô¸ð´Â CAGR 8.19%·Î ¼ºÀåÇØ 2030³â¿¡´Â 5,822¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è Àΰø°Ç ¹× Àδë½ÃÀåÀº ½ºÆ÷Ã÷ ºÎ»ó Áõ°¡, »ýüÀç·á Áøº¸, °üÀýÀå¾Ö À¯º´·ü »ó½Â, ÀÎÁöµµ Çâ»ó, ³ë³â Àα¸ Áõ°¡ µîÀ¸·Î ȰȲÀ» º¸À̰í ÀÖ½À´Ï´Ù.

Àü·« ÄÁ¼³ÆÃ ¹× ½ÃÀå Á¶»ç ȸ»çÀÎ BlueWeave ConsultingÀº ÃÖ±Ù Á¶»ç¿¡¼­ 2023³â ¼¼°è Àΰø°Ç ¹× ÀÎ´ë ½ÃÀå ±Ô¸ð¸¦ ±Ý¾× ±âÁØÀ¸·Î 3,712¸¸ ´Þ·¯·Î ÃßÁ¤Çß½À´Ï´Ù. 2024³âºÎÅÍ 2030³â±îÁöÀÇ ¿¹Ãø ±â°£¿¡ BlueWeave»ç´Â Àΰø°Ç ¹× ÀÎ´ë ¼¼°è ½ÃÀå ±Ô¸ð°¡ CAGR 8.19%·Î È®´ëµÇ¾î 2030³â¿¡´Â 5,822¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. Àΰø°Ç ¹× ÀÎ´ë ¼¼°è ½ÃÀåÀº ½ºÆ÷Ã÷ ºÎ»ó ¹ß»ý·ü Áõ°¡¿Í ±Ù°ñ°Ý°è Àå¾ÖÀÇ À¯º´·ü Áõ°¡¿¡ ÀÇÇØ °ßÀεǰí ÀÖ½À´Ï´Ù. »ýü Àç·á ±â¼úÀÇ Áøº¸´Â Á¦Ç°ÀÇ È¿´É°ú »ýü ÀûÇÕ¼ºÀ» Çâ»ó½ÃŰ°í ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ³·Àº ħ½À ¼ö¼ú¿¡ ´ëÇÑ Àνİú ¼ö¿ë Áõ°¡µµ ¼ö¿ä¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ÈûÁÙÀ̳ª Àδ븦 ¼Õ»ó½ÃŰ±â ½¬¿î °í·ÉÈ­ »çȸ¿Í ÀÇ·áºñ Áõ°¡°¡ ½ÃÀå È®´ë¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í Á¤Çü¿Ü°ú ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Áö¿øÀº ½ÃÀå ¿ªÇп¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù.

±âȸ - ºñ¿ë Àý°¨¿¡ ÁÖ·Â

¼¼°è Àΰø°Ç ¹× Àδë½ÃÀåÀº ¾÷°è Àüü°¡ ºñ¿ë Àý°¨¿¡ ÁÖ·ÂÇϰí ÀÖ´Â °ÍÀÌ ¿øµ¿·ÂÀÌ µÇ¾î Å« ¼ºÀåÀ» ÀÌ·ç·Á°í Çϰí ÀÖ½À´Ï´Ù. Á¦Á¶ ±â¼ú°ú Àç·áÀÇ Áøº¸·Î Á¦Á¶ ºñ¿ëÀÌ ³·¾ÆÁö°í ÀÌ·¯ÇÑ ÀÇ·á±â±â°¡ ´õ¿í Ä£¼÷ÇØÁö°í ÀÖ½À´Ï´Ù. ±Ô¸ðÀÇ °æÁ¦, °ø±Þ¸Á È¿À²¼º °³¼±, °æÀï·Â ÀÖ´Â °¡°Ý Àü·«ÀÌ ºñ¿ë Àý°¨¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °æÁ¦Àû ÀÌÁ¡Àº ¼±Áø±¹ ½ÃÀå°ú ½ÅÈï±¹ ½ÃÀå ¸ðµÎ¿¡¼­ Æø³ÐÀº º¸±ÞÀ» ÃËÁøÇϰí, Àú·ÅÇÑ °¡°ÝÀ» À¯ÁöÇϸ鼭 ȯÀÚÀÇ °á°ú¸¦ Çâ»ó½Ã۰í, ½ÃÀå È®´ë¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù.

ÁöÁ¤ ÇÐÀû ±äÀå Áõ°¡°¡ Àΰø°Ç ¹× ÀÎ´ë ¼¼°è ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

ÁöÁ¤ÇÐÀû ±äÀå Áõ°¡´Â °ø±Þ¸ÁÀ» È¥¶õ½ÃŰ°í »ý»ê ºñ¿ëÀ» Áõ°¡½ÃŰ°í ½ÃÀåÀ» ºÒ¾ÈÁ¤ÇÏ°Ô ÇÔÀ¸·Î½á ¼¼°è Àΰø°Ç ¹× ÀÎ´ë ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹°ú Áß±¹°ú °°Àº ÁÖ¿ä °æÁ¦±¹ °£ÀÇ ¹«¿ª ¸¶ÂûÀº ÇʼöÀûÀÎ ¿ø·á ¹× ÀÇ·á ºÎǰ¿¡ °ü¼¼¸¦ ºÎ°úÇÏ¿© ºñ¿ëÀÌ »ó½ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ·¯½Ã¾Æ¿Í ¿ìÅ©¶óÀ̳ªÀÇ ºÐÀïÀº À¯·´ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÇ·á Á¦Ç°ÀÇ ¹è´Þ Áö¿¬À» À¯¹ßÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±äÀåÀº °æÁ¦Àû ºÒÈ®½Ç¼ºÀ¸·Î ÀÎÇØ °Ç°­ °ü¸® Çõ½Å¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ±ÔÁ¦ÀÇ º¯°æÀ̳ª Á¦ÀçÁ¶Ä¡¿¡ ÀÇÇØ ÷´ÜÀç·á³ª ±â¼úÀÇ ÀÔ¼ö°¡ Á¦ÇÑµÇ¾î ½ÃÀåÀÇ ¼ºÀåÀ» ¹æÇØÇÒ °¡´É¼ºµµ ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î, ÁöÁ¤ÇÐÀû ºÒ¾ÈÁ¤Àº Àΰø°Ç ¹× Àδë½ÃÀå¿¡ ¾î·Á¿î ȯ°æÀ» ¸¸µé°í, ¼¼°èÀÇ È®´ë¿Í Çõ½ÅÀÇ ³ë·Â¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

Àΰø°Ç ¹× ÀÎ´ë ¼¼°è ½ÃÀå

ºÎ¹®º° Ä¿¹ö¸®Áö

Àΰø°Ç ¹× ÀÎ´ë ¼¼°è ½ÃÀå - Á¦Ç° À¯Çüº°

Á¦Ç° À¯Çüº°·Î ¼¼°è Àΰø°Ç ¹× Àδë½ÃÀåÀº Àü½ÊÀÚÀδë(ACL)ġȯ, ÈĽÊÀÚÀδë(PCL)ġȯ, ¹Ý¿ùÆÇġȯ, °ÇÆÇ¼öº¹ÈûÁÙ, ±âŸ(±¼±Ù°Ç, ¾ÆÅ³·¹½º°Ç) ºÎ¹®À¸·Î ³ª´¹´Ï´Ù. Àü ½ÊÀÚ Àδë(ACL) ´ëü Á¦Ç° À¯ÇüÀº ¼¼°è Àΰø °Ç°ú ÀÎ´ë ½ÃÀå¿¡¼­ °¡Àå Å« ºÎ¹®ÀÔ´Ï´Ù. ACL ´ëü¼úÀº ƯÈ÷ ½ºÆ÷Ã÷ ¼±¼öµé »çÀÌ¿¡¼­ ACL ¼Õ»óÀÇ ¹ß»ý·üÀÌ ³ô°í °í±Þ ¼ö¼ú ±â¼úÀÌ ³Î¸® äÅÃµÇ¾î ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. ACL ´ëü ¼ö¼úÀº ¹«¸­ÀÇ ¾ÈÁ¤¼º°ú ±â´É¼ºÀ» ȸº¹½ÃŰ´Â È¿°úÀûÀÎ Ä¡·á ¿É¼ÇÀÇ Çʿ伺¿¡ ÀÇÇØ °ßÀÎµÇ¾î ½ÃÀå¿¡¼­ Å« Á¡À¯À²À» Â÷ÁöÇÕ´Ï´Ù. »ýüÀç·áÀÇ Áö¼ÓÀûÀÎ Áøº¸¿Í ³·Àº ħ½À ¼ö¼ú¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö¸é Àΰø°Ç ¹× ÀÎ´ë ºÐ¾ß¿¡¼­ ACL ġȯ¼úÀÇ ¿ìÀ§¼ºÀÌ ´õ¿í ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

Àΰø°Ç ¹× ÀÎ´ë ¼¼°è ½ÃÀå - ¿ëµµº°

Àΰø°Ç ¹× ÀÎ´ë ¼¼°è ½ÃÀåÀº ¿ëµµº°·Î ¹«¸­ °üÀý, ¾î±ú °üÀý, ¹ß °üÀý ¹× ±âŸ ºÎ»óÀ¸·Î ºÐ·ùµË´Ï´Ù. Àΰø°Ç ¹× ÀÎ´ë ¼¼°è ½ÃÀå¿¡¼­ ¹«¸­ ºÎ»óÀÇ ¿ëµµ°¡ °¡Àå Å®´Ï´Ù. ÀÌ·¯ÇÑ ÀÌÁ¡Àº ƯÈ÷ ½ºÆ÷Ã÷ ¼±¼ö¿Í ³ëÀÎ Áß ¹«¸­ °üÀý ¼Õ»óÀÇ ¹ß»ý·üÀÌ ³ô±â ¶§¹®ÀÔ´Ï´Ù. °ñ°üÀý¿°°ú °°Àº Áúº´ÀÇ À¯º´·ü Áõ°¡, ¼ö¼ú ¼ö¼úÀÇ Áøº¸, ³·Àº ħ½À ¼ö¼úÀÇ Ã¤¿ë Áõ°¡ µîÀÌ ¹«¸­ ¼Õ»ó¿ë Àΰø°Ç ¹× ÀÎ´ë ¼ö¿ä¸¦ ´õ¿í ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ß´Â Áö¼ÓÀûÀÎ R&D¸¦ ÅëÇØ Á¦Ç°ÀÇ °³¼±°ú ȯÀÚÀÇ ¿¹ÈÄ °³¼±À¸·Î À̾îÁ® ½ÃÀå¿¡¼­ ÁÖµµÀûÀÎ ÁöÀ§¸¦ À¯ÁöÇϰí ÀÖ½À´Ï´Ù.

°æÀï ±¸µµ

¼¼°è Àΰø°Ç ¹× Àδë½ÃÀåÀº °æÀïÀÌ ½ÉÇÕ´Ï´Ù. ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº LARS, Xiros Ltd, Orthomed SAS, Cousin Biotech SAS, Fx Solutions SAS, Arthrex, Inc. °è¾à, ½ÅÁ¦Ç° ¹× ¼­ºñ½º Ãâ½Ã µî ´Ù¾çÇÑ Àü·«À» Ȱ¿ëÇÏ¿© ¼¼°è Àΰø°Ç ¹× Àδë½ÃÀå¿¡¼­ÀÇ ÀÔÁö¸¦ ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ »ó¼¼ÇÑ ºÐ¼®Àº ¼¼°è Àΰø °Ç°ú ÀÎ´ë ½ÃÀåÀÇ ¼ºÀå °¡´É¼º, ¹Ì·¡ µ¿Çâ ¹× Åë°è¿¡ ´ëÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÃÑ ½ÃÀå ±Ô¸ð ¿¹ÃøÀ» ÃËÁøÇÏ´Â ¿äÀο¡µµ ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù. ÀÌ º¸°í¼­´Â ¼¼°è Àΰø °Ç°ú ÀÎ´ë ½ÃÀåÀÇ Ãֽбâ¼ú µ¿Çâ°ú ÀÇ»ç °áÁ¤ÀÚ°¡ °ÇÀüÇÑ Àü·«Àû ÀÇ»ç °áÁ¤À» ¼öÇàÇÏ´Â ¾÷°è ÀλçÀÌÆ®·ÂÀ» Á¦°øÇÒ °ÍÀ» ¾à¼ÓÇÕ´Ï´Ù. ¶ÇÇÑ ½ÃÀåÀÇ ¼ºÀå ÃËÁø¿äÀΡ¤°úÁ¦¡¤°æÀï·Â¿¡ ´ëÇØ¼­µµ ºÐ¼®Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ÇÁ·¹ÀÓ¿öÅ©

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¼¼°èÀÇ Àΰø°Ç ¹× Àδë½ÃÀå ÀλçÀÌÆ®

  • ¾÷°è ¹ë·ùüÀÎ ºÐ¼®
  • DROC ºÐ¼®
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ½ºÆ÷Ã÷ ºÎ»ó Áõ°¡
      • °í·ÉÈ­ Àα¸ Áõ°¡
      • Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁø´Ù
      • Àΰø°Ç ¹× ÀδëÀÇ ÀåÁ¡
    • ¾ïÁ¦¿äÀÎ
      • Ä¡·áºñÀÇ »ó½Â
      • ÇコÄɾî Á¾»çÀÚÀÇ ¸Á¼³ÀÓ
      • Àå±â µ¥ÀÌÅÍ´Â ÇÑÁ¤µÇ¾î ÀÖ´Ù
    • ±âȸ
      • ±â¼úÀÇ Áøº¸
      • ºñ¿ë Àý°¨¿¡ ÁÖ·Â
      • ½ÅÈï ½ÃÀå
    • °úÁ¦
      • ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç
      • ÀüÅëÀûÀÎ ¹æ¹ý°úÀÇ °æÀï
  • ±â¼ú Áøº¸/ÃÖ±Ù µ¿Çâ
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ Àΰø°Ç ¹× Àδë½ÃÀå : ¸¶ÄÉÆÃ Àü·«

Á¦5Àå ¼¼°èÀÇ Àΰø°Ç ¹× Àδë½ÃÀå : °¡°Ý ºÐ¼®

Á¦6Àå ¼¼°èÀÇ Àΰø°Ç ¹× Àδë½ÃÀå : Áö¿ª ºÐ¼®

  • ¼¼°èÀÇ Àΰø°Ç ¹× ÀÎ´ë ½ÃÀå, Áö¿ª ºÐ¼®, 2023³â
  • ¼¼°èÀÇ Àΰø°Ç ¹× ÀÎ´ë ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, 2024-2030³â

Á¦7Àå ¼¼°èÀÇ Àΰø°Ç ¹× Àδë½ÃÀå °³¿ä

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2019-2030³â
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
      • Àü½ÊÀÚ Àδë(ACL) ġȯ¼ú
      • ÈĽÊÀÚ Àδë(PCL) ġȯ¼ú
      • ¹Ý¿ùÆÇ ġȯ¼ú
      • ÈûÁÙ ¼ö¸® ÈûÁÙ
      • ±âŸ(±¼±Ù°Ç, ¾ÆÅ³·¹½º°Ç)
    • ¿ëµµº°
      • ¹«¸­ ºÎ»ó
      • ¾î±ú ºÎ»ó
      • ¹ß°ú ¹ß¸ñ ºÎ»ó
      • ±âŸ »óÇØ
    • ÃÖÁ¾ »ç¿ëÀÚº°
      • º´¿ø
      • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
      • ±âŸ(½ºÆ÷Ã÷ ÀÇÇРŬ¸®´Ð)
    • ¼ÒÀ纰
      • ÇÕ¼º Æú¸®¸Ó(¿¹: Æú¸®¿¡½ºÅ׸£, Æú¸®¿¡Æ¿·»)
      • Äݶó°Õ ±â¹Ý ¼ÒÀç
      • ÀÌÁ¾À̽Ä(µ¿¹° À¯·¡ Á¶Á÷)
      • ±âŸ(»ýºÐÇØ¼º Àç·á)
    • ±¹°¡º°
      • ºÏ¹Ì
      • À¯·´
      • ¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
      • ¶óƾ¾Æ¸Þ¸®Ä«(LATAM)
      • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«(Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«)

Á¦8Àå ºÏ¹ÌÀÇ Àΰø°Ç ¹× Àδë½ÃÀå

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2019-2030³â
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ¼ÒÀ纰
    • ±¹°¡º°
      • ¹Ì±¹
      • ij³ª´Ù

Á¦9Àå À¯·´ Àΰø°Ç ¹× Àδë½ÃÀå

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2019-2030³â
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ¼ÒÀ纰
    • ±¹°¡º°
      • µ¶ÀÏ
      • ¿µ±¹
      • ÀÌÅ»¸®¾Æ
      • ÇÁ¶û½º
      • ½ºÆäÀÎ
      • º§±â¿¡
      • ·¯½Ã¾Æ
      • ³×´ú¶õµå
      • ±âŸ À¯·´

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Àΰø°Ç ¹× Àδë½ÃÀå

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2019-2030³â
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ¼ÒÀ纰
    • ±¹°¡º°
      • Áß±¹
      • Àεµ
      • ÀϺ»
      • Çѱ¹
      • È£ÁÖ ¹× ´ºÁú·£µå
      • Àεµ³×½Ã¾Æ
      • ¸»·¹À̽þÆ
      • ½Ì°¡Æ÷¸£
      • º£Æ®³²
      • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±âŸ ±¹°¡

Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä« Àΰø°Ç ¹× Àδë½ÃÀå

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2019-2030³â
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ¼ÒÀ纰
    • ±¹°¡º°
      • ºê¶óÁú
      • ¸ß½ÃÄÚ
      • ¾Æ¸£ÇîÆ¼³ª
      • Æä·ç
      • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«

Á¦12Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« Àΰø°Ç ¹× Àδë½ÃÀå

  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, 2019-2030³â
    • ±Ý¾×º°
  • ½ÃÀå Á¡À¯À²°ú ¿¹Ãø
    • Á¦Ç° À¯Çüº°
    • ¿ëµµº°
    • ÃÖÁ¾ »ç¿ëÀÚº°
    • ¼ÒÀ纰
    • ±¹°¡º°
      • »ç¿ìµð¾Æ¶óºñ¾Æ
      • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
      • īŸ¸£
      • Äí¿þÀÌÆ®
      • ³²¾ÆÇÁ¸®Ä«
      • ³ªÀÌÁö¸®¾Æ
      • ¾ËÁ¦¸®
      • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ³ª¸ÓÁö

Á¦13Àå °æÀï ±¸µµ

  • ÁÖ¿ä ±â¾÷°ú ±× ÃËÁø¿äÀÎÀÇ ¸®½ºÆ®
  • 2023³â ¼¼°è ±â¾÷ ´ëÃâ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • °æ¿µ ÆÄ¶ó¹ÌÅÍ¿¡ ÀÇÇÑ °æÀï º¥Ä¡¸¶Å·
  • ÁÖ¿ä Àü·«Àû Àü°³(ÇÕº´, Àμö, Á¦ÈÞ µî)

Á¦14Àå ¼¼°èÀÇ Àΰø°Ç ¹× Àδë½ÃÀå : ¼öÀÔ°ú ¼öÃâ

Á¦15Àå Áõ°¡ÇÏ´Â ÁöÁ¤ÇÐÀû ±äÀåÀÌ ¼¼°è Àΰø°Ç ¹× Àδë½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦16Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ(±â¾÷ °³¿ä, À繫 ¸ÅÆ®¸¯½º, °æÀï ±¸µµ, ÁÖ¿ä Àι°, ÁÖ¿ä °æÀï, ¿¬¶ôó, Àü·« Àü¸Á, SWOT ºÐ¼®)

  • LARS
  • Xiros Ltd
  • Orthomed SAS
  • Cousin Biotech SAS
  • Fx Solutions SAS
  • Arthrex, Inc.
  • Shanghai PINE&POWER Biotech
  • Mathys AG Bettlach
  • ArthroCare Corporation
  • FH ORTHOPEDICS SAS
  • ±âŸ ÁÖ¿ä ±â¾÷

Á¦17Àå ÁÖ¿ä Àü·«Àû Á¦¾È

Á¦18Àå Á¶»ç ¹æ¹ý

JHS 24.09.04

Global Artificial Tendons and Ligaments Market Size Growth Sprinting at Significant CAGR of 8.19% to Touch Value of USD 58.22 Million by 2030

Global Artificial Tendons and Ligaments Market is flourishing due to increasing incidences of sports injuries, advancements in biomaterials, rising prevalence of joint disorders, growing awareness, and growing geriatric population.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Artificial Tendons and Ligaments Market size by value at USD 37.12 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Artificial Tendons and Ligaments Market size to expand at a CAGR of 8.19% reaching a value of USD 58.22 million by 2030. The Global Artificial Tendons and Ligaments Market is driven by the rising incidence of sports injuries and the increasing prevalence of musculoskeletal disorders. Advances in biomaterial technology enhance product efficacy and biocompatibility, propelling market growth. Growing awareness and acceptance of minimally invasive surgical procedures also boost demand. Additionally, an aging population, which is more prone to tendon and ligament injuries, along with increasing healthcare expenditure, supports market expansion. Government initiatives and funding for orthopedic research further contribute to market dynamics.

Opportunity - Focus on cost reduction

Global Artificial Tendons and Ligaments Market is poised for significant growth, driven by an industry-wide focus on cost reduction. Advances in manufacturing technologies and materials have led to lower production costs, making these medical devices more accessible. Economies of scale, improved supply chain efficiencies, and competitive pricing strategies are further contributing to cost reductions. These financial benefits are facilitating broader adoption in both developed and emerging markets, enhancing patient outcomes while maintaining affordability, thereby fueling market expansion.

Impact of Escalating Geopolitical Tensions on Global Artificial Tendons and Ligaments Market

Escalating geopolitical tensions significantly impacts the Global Artificial Tendons and Ligaments Market by disrupting supply chains, increasing production costs, and creating market instability. For instance, trade conflicts between major economies like the United States and China can lead to tariffs on essential raw materials and medical components, thereby inflating costs. Additionally, the Russia-Ukraine conflict has affected European markets, causing delays in the delivery of medical products. These tensions can also lead to reduced investments in healthcare innovation due to economic uncertainty. Further, regulatory changes and sanctions can limit the availability of advanced materials and technologies, hindering market growth. Overall, geopolitical instability creates a challenging environment for the artificial tendons and ligaments market, impacting its global expansion and innovation efforts.

Global Artificial Tendons and Ligaments Market

Segmental Coverage

Global Artificial Tendons and Ligaments Market - By Product Type

Based on product type, Global Artificial Tendons and Ligaments Market is divided into Anterior Cruciate Ligament (ACL) Replacements, Posterior Cruciate Ligament (PCL) Replacements, Meniscus Replacements, Rotator Cuff Repair Tendons, and Other (Flexor Tendons, Achilles Tendons) segments. The anterior cruciate ligament (ACL) replacement product type is the largest segment in the Global Artificial Tendons and Ligaments Market. ACL replacements dominate the market due to the high incidence of ACL injuries, especially among athletes, and the widespread adoption of advanced surgical techniques. The demand for ACL replacement procedures is driven by the need for effective treatment options that restore knee stability and functionality, leading to a significant share of the market. Continuous advancements in biomaterials and growing awareness about minimally invasive surgeries further bolster the prominence of ACL replacements in the artificial tendons and ligaments sector.

Global Artificial Tendons and Ligaments Market - By Application

Based on application, Global Artificial Tendons and Ligaments Market is divided into Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries, and Other Injuries segments. The knee injury application is the largest in the Global Artificial Tendons and Ligaments Market. The dominance is attributed to the high incidence of knee injuries, particularly among athletes and the elderly. The increasing prevalence of conditions like osteoarthritis, advancements in surgical techniques, and the rising adoption of minimally invasive procedures further drive the demand for artificial tendons and ligaments for knee injuries. The segment benefits from continuous research and development, leading to improved products and better patient outcomes, thus maintaining its leading position in the market.

Competitive Landscape

Global Artificial Tendons and Ligaments Market is fiercely competitive. Major companies in the market include LARS, Xiros Ltd, Orthomed S.A.S, Cousin Biotech SAS, Fx Solutions S.A.S, Arthrex, Inc., Shanghai Pine&Power Biotech, Mathys AG Bettlach, ArthroCare Corporation, and FH Orthopedics S.A.S. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Global Artificial Tendons and Ligaments Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Artificial Tendons and Ligaments Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Global Artificial Tendons and Ligaments Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Artificial Tendons and Ligaments Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Incidence of Sports Injuries
      • 3.2.1.2. Rising Geriatric Population
      • 3.2.1.3. Growing Preference for Minimally Invasive Surgeries
      • 3.2.1.4. Benefits of Artificial Tendons and Ligaments
    • 3.2.2. Restraints
      • 3.2.2.1. High Cost of Treatment
      • 3.2.2.2. Hesitation Among Healthcare Providers
      • 3.2.2.3. Limited Long-Term Data
    • 3.2.3. Opportunities
      • 3.2.3.1. Technological Advancements
      • 3.2.3.2. Focus on Cost Reduction
      • 3.2.3.3. Emerging Markets
    • 3.2.4. Challenges
      • 3.2.4.1. Stringent Regulatory Requirements
      • 3.2.4.2. Competition from Traditional Methods
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Artificial Tendons and Ligaments Market: Marketing Strategies

5. Global Artificial Tendons and Ligaments Market: Pricing Analysis

6. Global Artificial Tendons and Ligaments Market: Geography Analysis

  • 6.1. Global Artificial Tendons and Ligaments Market, Geographical Analysis, 2023
  • 6.2. Global Artificial Tendons and Ligaments Market Attractiveness Analysis, 2024-2030

7. Global Artificial Tendons and Ligaments Market Overview

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
      • 7.2.1.1. Anterior Cruciate Ligament (ACL) replacements
      • 7.2.1.2. Posterior Cruciate Ligament (PCL) replacements
      • 7.2.1.3. Meniscus replacements
      • 7.2.1.4. Rotator Cuff repair tendons
      • 7.2.1.5. Other (flexor tendons, Achilles tendons)
    • 7.2.2. By Application
      • 7.2.2.1. Knee Injuries
      • 7.2.2.2. Shoulder Injuries
      • 7.2.2.3. Foot & Ankle Injuries
      • 7.2.2.4. Other Injuries
    • 7.2.3. By End User
      • 7.2.3.1. Hospitals
      • 7.2.3.2. Ambulatory Surgical Centers
      • 7.2.3.3. Other (sports medicine clinics)
    • 7.2.4. By Material
      • 7.2.4.1. Synthetic Polymers (e.g., polyester, polyethylene)
      • 7.2.4.2. Collagen-based materials
      • 7.2.4.3. Xenografts (animal-derived tissues)
      • 7.2.4.4. Others (biodegradable materials)
    • 7.2.5. By Country
      • 7.2.5.1. North America
      • 7.2.5.2. Europe
      • 7.2.5.3. Asia Pacific (APAC)
      • 7.2.5.4. Latin America (LATAM)
      • 7.2.5.5. Middle East and Africa (MEA)

8. North America Artificial Tendons and Ligaments Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Material
    • 8.2.5. By Country
      • 8.2.5.1. United States
      • 8.2.5.1.1. By Product Type
      • 8.2.5.1.2. By Application
      • 8.2.5.1.3. By End User
      • 8.2.5.1.4. By Material
      • 8.2.5.2. Canada
      • 8.2.5.2.1. By Product Type
      • 8.2.5.2.2. By Application
      • 8.2.5.2.3. By End User
      • 8.2.5.2.4. By Material

9. Europe Artificial Tendons and Ligaments Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Material
    • 9.2.5. By Country
      • 9.2.5.1. Germany
      • 9.2.5.1.1. By Product Type
      • 9.2.5.1.2. By Application
      • 9.2.5.1.3. By End User
      • 9.2.5.1.4. By Material
      • 9.2.5.2. United Kingdom
      • 9.2.5.2.1. By Product Type
      • 9.2.5.2.2. By Application
      • 9.2.5.2.3. By End User
      • 9.2.5.2.4. By Material
      • 9.2.5.3. Italy
      • 9.2.5.3.1. By Product Type
      • 9.2.5.3.2. By Application
      • 9.2.5.3.3. By End User
      • 9.2.5.3.4. By Material
      • 9.2.5.4. France
      • 9.2.5.4.1. By Product Type
      • 9.2.5.4.2. By Application
      • 9.2.5.4.3. By End User
      • 9.2.5.4.4. By Material
      • 9.2.5.5. Spain
      • 9.2.5.5.1. By Product Type
      • 9.2.5.5.2. By Application
      • 9.2.5.5.3. By End User
      • 9.2.5.5.4. By Material
      • 9.2.5.6. Belgium
      • 9.2.5.6.1. By Product Type
      • 9.2.5.6.2. By Application
      • 9.2.5.6.3. By End User
      • 9.2.5.6.4. By Material
      • 9.2.5.7. Russia
      • 9.2.5.7.1. By Product Type
      • 9.2.5.7.2. By Application
      • 9.2.5.7.3. By End User
      • 9.2.5.7.4. By Material
      • 9.2.5.8. The Netherlands
      • 9.2.5.8.1. By Product Type
      • 9.2.5.8.2. By Application
      • 9.2.5.8.3. By End User
      • 9.2.5.8.4. By Material
      • 9.2.5.9. Rest of Europe
      • 9.2.5.9.1. By Product Type
      • 9.2.5.9.2. By Application
      • 9.2.5.9.3. By End User
      • 9.2.5.9.4. By Material

10. Asia Pacific Artificial Tendons and Ligaments Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Material
    • 10.2.5. By Country
      • 10.2.5.1. China
      • 10.2.5.1.1. By Product Type
      • 10.2.5.1.2. By Application
      • 10.2.5.1.3. By End User
      • 10.2.5.1.4. By Material
      • 10.2.5.2. India
      • 10.2.5.2.1. By Product Type
      • 10.2.5.2.2. By Application
      • 10.2.5.2.3. By End User
      • 10.2.5.2.4. By Material
      • 10.2.5.3. Japan
      • 10.2.5.3.1. By Product Type
      • 10.2.5.3.2. By Application
      • 10.2.5.3.3. By End User
      • 10.2.5.3.4. By Material
      • 10.2.5.4. South Korea
      • 10.2.5.4.1. By Product Type
      • 10.2.5.4.2. By Application
      • 10.2.5.4.3. By End User
      • 10.2.5.4.4. By Material
      • 10.2.5.5. Australia & New Zealand
      • 10.2.5.5.1. By Product Type
      • 10.2.5.5.2. By Application
      • 10.2.5.5.3. By End User
      • 10.2.5.5.4. By Material
      • 10.2.5.6. Indonesia
      • 10.2.5.6.1. By Product Type
      • 10.2.5.6.2. By Application
      • 10.2.5.6.3. By End User
      • 10.2.5.6.4. By Material
      • 10.2.5.7. Malaysia
      • 10.2.5.7.1. By Product Type
      • 10.2.5.7.2. By Application
      • 10.2.5.7.3. By End User
      • 10.2.5.7.4. By Material
      • 10.2.5.8. Singapore
      • 10.2.5.8.1. By Product Type
      • 10.2.5.8.2. By Application
      • 10.2.5.8.3. By End User
      • 10.2.5.8.4. By Material
      • 10.2.5.9. Vietnam
      • 10.2.5.9.1. By Product Type
      • 10.2.5.9.2. By Application
      • 10.2.5.9.3. By End User
      • 10.2.5.9.4. By Material
      • 10.2.5.10. Rest of APAC
      • 10.2.5.10.1. By Product Type
      • 10.2.5.10.2. By Application
      • 10.2.5.10.3. By End User
      • 10.2.5.10.4. By Material

11. Latin America Artificial Tendons and Ligaments Market

  • 11.1. Market Size & Forecast, 2019-2030
    • 11.1.1. By Value (USD Million)
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product Type
    • 11.2.2. By Application
    • 11.2.3. By End User
    • 11.2.4. By Material
    • 11.2.5. By Country
      • 11.2.5.1. Brazil
      • 11.2.5.1.1. By Product Type
      • 11.2.5.1.2. By Application
      • 11.2.5.1.3. By End User
      • 11.2.5.1.4. By Material
      • 11.2.5.2. Mexico
      • 11.2.5.2.1. By Product Type
      • 11.2.5.2.2. By Application
      • 11.2.5.2.3. By End User
      • 11.2.5.2.4. By Material
      • 11.2.5.3. Argentina
      • 11.2.5.3.1. By Product Type
      • 11.2.5.3.2. By Application
      • 11.2.5.3.3. By End User
      • 11.2.5.3.4. By Material
      • 11.2.5.4. Peru
      • 11.2.5.4.1. By Product Type
      • 11.2.5.4.2. By Application
      • 11.2.5.4.3. By End User
      • 11.2.5.4.4. By Material
      • 11.2.5.5. Rest of LATAM
      • 11.2.5.5.1. By Product Type
      • 11.2.5.5.2. By Application
      • 11.2.5.5.3. By End User
      • 11.2.5.5.4. By Material

12. Middle East & Africa Artificial Tendons and Ligaments Market

  • 12.1. Market Size & Forecast, 2019-2030
    • 12.1.1. By Value (USD Million)
  • 12.2. Market Share & Forecast
    • 12.2.1. By Product Type
    • 12.2.2. By Application
    • 12.2.3. By End User
    • 12.2.4. By Material
    • 12.2.5. By Country
      • 12.2.5.1. Saudi Arabia
      • 12.2.5.1.1. By Product Type
      • 12.2.5.1.2. By Application
      • 12.2.5.1.3. By End User
      • 12.2.5.1.4. By Material
      • 12.2.5.2. UAE
      • 12.2.5.2.1. By Product Type
      • 12.2.5.2.2. By Application
      • 12.2.5.2.3. By End User
      • 12.2.5.2.4. By Material
      • 12.2.5.3. Qatar
      • 12.2.5.3.1. By Product Type
      • 12.2.5.3.2. By Application
      • 12.2.5.3.3. By End User
      • 12.2.5.3.4. By Material
      • 12.2.5.4. Kuwait
      • 12.2.5.4.1. By Product Type
      • 12.2.5.4.2. By Application
      • 12.2.5.4.3. By End User
      • 12.2.5.4.4. By Material
      • 12.2.5.5. South Africa
      • 12.2.5.5.1. By Product Type
      • 12.2.5.5.2. By Application
      • 12.2.5.5.3. By End User
      • 12.2.5.5.4. By Material
      • 12.2.5.6. Nigeria
      • 12.2.5.6.1. By Product Type
      • 12.2.5.6.2. By Application
      • 12.2.5.6.3. By End User
      • 12.2.5.6.4. By Material
      • 12.2.5.7. Algeria
      • 12.2.5.7.1. By Product Type
      • 12.2.5.7.2. By Application
      • 12.2.5.7.3. By End User
      • 12.2.5.7.4. By Material
      • 12.2.5.8. Rest of MEA
      • 12.2.5.8.1. By Product Type
      • 12.2.5.8.2. By Application
      • 12.2.5.8.3. By End User
      • 12.2.5.8.4. By Material

13. Competitive Landscape

  • 13.1. List of Key Players and Their Drive Types
  • 13.2. Global Corporate Lending Company Market Share Analysis, 2023
  • 13.3. Competitive Benchmarking, By Operating Parameters
  • 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

14. Global Artificial Tendons and Ligaments Market: Import & Export

15. Impact of Escalating Geopolitical Tensions on Global Artificial Tendons and Ligaments Market

16. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 16.1. LARS
  • 16.2. Xiros Ltd
  • 16.3. Orthomed S.A.S
  • 16.4. Cousin Biotech SAS
  • 16.5. Fx Solutions S.A.S
  • 16.6. Arthrex, Inc.
  • 16.7. Shanghai PINE&POWER Biotech
  • 16.8. Mathys AG Bettlach
  • 16.9. ArthroCare Corporation
  • 16.10. FH ORTHOPEDICS S.A.S
  • 16.11. Other Prominent Players

17. Key Strategic Recommendations

18. Research Methodology

  • 18.1. Qualitative Research
    • 18.1.1. Primary & Secondary Research
  • 18.2. Quantitative Research
  • 18.3. Market Breakdown & Data Triangulation
    • 18.3.1. Secondary Research
    • 18.3.2. Primary Research
  • 18.4. Breakdown of Primary Research Respondents, By Region
  • 18.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦